Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study

Eur Respir J. 2015 Oct;46(4):1211-4. doi: 10.1183/13993003.00051-2015. Epub 2015 Jul 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amines / administration & dosage
  • Amphetamines / administration & dosage
  • Case-Control Studies
  • Female
  • Humans
  • Hypertension, Pulmonary / chemically induced
  • Hypertension, Pulmonary / drug therapy*
  • Inflammation / drug therapy*
  • Male
  • Middle Aged
  • Naphazoline / administration & dosage
  • Nasal Decongestants / administration & dosage*
  • Nasal Decongestants / adverse effects
  • Oxymetazoline / administration & dosage
  • Phenylpropanolamine / administration & dosage
  • Pilot Projects
  • Pseudoephedrine / administration & dosage
  • Young Adult

Substances

  • Amines
  • Amphetamines
  • Nasal Decongestants
  • Phenylpropanolamine
  • Pseudoephedrine
  • Oxymetazoline
  • Naphazoline
  • tuaminoheptane